Do you want to read an article? Please log in or register.
Hormonal contraception is not associated with recurrent flares in ulcerative colitis: a longitudinal time-dependent analysis
Inflammatory Bowel Disease
Related content
Gastrointestinal Cancer
Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4)
Eur J Cancer
Tashiro K, Osumi H, Kataoka K, Shimada Y, Inomata M, Hamaguchi T, Takii Y, Suwa Y, Mizusawa J, Sano Y, Suto T, Murata K, Adachi T, Ueno H, Ikeda S, Komori K, Shiozawa M, Tsukamoto S, Takashima A, Kanemitsu Y
doi: 10.1016/j.ejca.2026.116957
Inflammatory Bowel Disease
Mechanistic insights into FMT for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial
J Crohns Colitis
Quraishi MN, Moakes CA, Yalchin M, Blackwell C, Segal J, Ives NJ, Magill L, Manzoor SE, Gerasimidis K, McMullan C, Mathers J, Horniblow R, Loi S, Kaur M, Loman NJ, Sharma N, Hawkey P, McCune V, Quick J, Nicholls S, McMurray C, Nichols B, Svolos V, Raguideau S, Kerbiriou C, Oo YH, Beggs AD, Crees N, Hansen R, Hart AL, Gaya DR, Quince C, Iqbal TH
doi: 10.1093/ecco-jcc/jjag006
Inflammatory Bowel Disease
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinib
J Crohns Colitis
Magro F, Rogler G, Feagan BG, Peyrin-Biroulet L, Oortwijn A, Cougnaud L, Faes M, Bauer Y, Randall M, Rudolph C, Reinisch W
doi: 10.1093/ecco-jcc/jjaf228
Inflammatory Bowel Disease
Placebo rates in randomised clinical trials of ulcerative colitis: An individual patient data meta-analysis
J Crohns Colitis
Solitano V, Hogan M, Singh S, Danese S, Peyrin-Biroulet L, Vuyyuru S, Macdonald JK, Zou G, Yuan Y, Sands BE, Panaccione R, Feagan BG, Hanzel J, Sedano R, Dulai P, Narula N, Ma C, Jairath V
doi: 10.1093/ecco-jcc/jjaf191
RECOMMENDED
Inflammatory Bowel Disease
Efficacy of 5-Aminosalicylic Acid Continuation versus Discontinuation in Patients with Ulcerative Colitis Escalated to Advanced Therapy: A Systematic Review and Meta-Analysis of Adjusted Effect Estimates
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Sul HH, Gewehr DM, Kang H, Junior OR, Ungaro RC, Bernstein CN
doi: 10.1093/ecco-jcc/jjaf202
Inflammatory Bowel Disease
Thromboembolic Risk in Ulcerative Colitis Patients on Advanced Therapy: A Real-World Data Analysis
Inflamm Bowel Dis
Nishida Y, Hosomi S, Fujimoto K, Kobayashi Y, Nakata R, Maruyama H, Ominami M, Nadatani Y, Fukunaga S, Otani K, Tanaka F, Fujiwara Y
doi: 10.1093/ibd/izaf302
Inflammatory Bowel Disease
Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease
J Gastroenterol Hepatol
Ooi CJ, Ling KL, Limsrivilai J, Wei SC, Mak JWY, Kobayashi T, Dang LM, Leong RW, Lin H, Weng MT, Ong WC, Ahuja V, Aniwan S, Hokari R, Lee WJJ, Leow AH, Leung WK, Lim WC, Makharia G, Matsuoka K, Mustaffa N, Ng SC, Philip M, Pisespongsa P, Ali RAR, Ran ZH, Simadibrata M, Sollano J, Tan M, Viet HD, Wan Ibrahim NR, Wu KC, Ye BD, Hilmi I, Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease Committee and Asian Education Network in IBD (AEN‐IBD)
doi: 10.1111/jgh.70379
Inflammatory Bowel Disease
Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials
Inflamm Bowel Dis
Wong ECL, Marshall JK, Ma C, Jairath V, Reinisch W, Narula N
doi: 10.1093/ibd/izag054
Hepatology
Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis
Lancet Gastroenterol Hepatol
Celsa C, Pennisi G, Tulone A, Ciancimino G, Vaccaro M, Pecorella F, Di Maria G, Enea M, Midiri F, Mantovani A, Targher G, Krag A, Rinella ME, Cammà C, Petta S
doi: 10.1016/S2468-1253(25)00188-8